Cargando…

Selected psychological aspects and medication adherence in oncological patients

OBJECTIVE: The aim of this study was to analyze the relationships between selected psychological features and adherence to therapy in oncological patients. METHODS: The study included 102 patients of oncological clinics, 66.67% of whom were female. The average (SD) age of the study subjects was 49.1...

Descripción completa

Detalles Bibliográficos
Autores principales: Gruszczyńska, Magdalena, Bąk‐Sosnowska, Monika, Szemik, Szymon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997052/
https://www.ncbi.nlm.nih.gov/pubmed/31837119
http://dx.doi.org/10.1002/cam4.2691
_version_ 1783493613143982080
author Gruszczyńska, Magdalena
Bąk‐Sosnowska, Monika
Szemik, Szymon
author_facet Gruszczyńska, Magdalena
Bąk‐Sosnowska, Monika
Szemik, Szymon
author_sort Gruszczyńska, Magdalena
collection PubMed
description OBJECTIVE: The aim of this study was to analyze the relationships between selected psychological features and adherence to therapy in oncological patients. METHODS: The study included 102 patients of oncological clinics, 66.67% of whom were female. The average (SD) age of the study subjects was 49.15 ± 18.16 years old. The following tools were used: Morisky Medication Adherence Questionnaire (MAQ‐4), Multidimensional Health Locus of Control, Coping Inventory for Stressful Situations, Personal Values Inventory (LWO), and a study‐specific survey questionnaire. RESULTS: High MAQ‐4 scores were declared by 39.2% of the subjects, medium scores by 32.3% and low scores by 28.5%. The values were higher in female patients (P = .23), younger subjects (P < .001), and in individuals with higher education (P = .03). The greatest adherence was observed in subjects who placed their locus of control in chance (P = .022). Significant relationships were identified between the level of medication adherence and the use of avoidance strategies of coping with stress (P = .037), including the willingness to engage in social relationships (P = .04). It was demonstrated that the risk of noncompliance in the analyzed group was associated with a lower assessment of appearance (OR = 0.75) and health (OR = 0.78) on the scale of values. CONCLUSION: Medication adherence in oncological patients is related to the health locus of control, strategies of coping with stress, and the value assigned to appearance and health.
format Online
Article
Text
id pubmed-6997052
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69970522020-02-05 Selected psychological aspects and medication adherence in oncological patients Gruszczyńska, Magdalena Bąk‐Sosnowska, Monika Szemik, Szymon Cancer Med Clinical Cancer Research OBJECTIVE: The aim of this study was to analyze the relationships between selected psychological features and adherence to therapy in oncological patients. METHODS: The study included 102 patients of oncological clinics, 66.67% of whom were female. The average (SD) age of the study subjects was 49.15 ± 18.16 years old. The following tools were used: Morisky Medication Adherence Questionnaire (MAQ‐4), Multidimensional Health Locus of Control, Coping Inventory for Stressful Situations, Personal Values Inventory (LWO), and a study‐specific survey questionnaire. RESULTS: High MAQ‐4 scores were declared by 39.2% of the subjects, medium scores by 32.3% and low scores by 28.5%. The values were higher in female patients (P = .23), younger subjects (P < .001), and in individuals with higher education (P = .03). The greatest adherence was observed in subjects who placed their locus of control in chance (P = .022). Significant relationships were identified between the level of medication adherence and the use of avoidance strategies of coping with stress (P = .037), including the willingness to engage in social relationships (P = .04). It was demonstrated that the risk of noncompliance in the analyzed group was associated with a lower assessment of appearance (OR = 0.75) and health (OR = 0.78) on the scale of values. CONCLUSION: Medication adherence in oncological patients is related to the health locus of control, strategies of coping with stress, and the value assigned to appearance and health. John Wiley and Sons Inc. 2019-12-14 /pmc/articles/PMC6997052/ /pubmed/31837119 http://dx.doi.org/10.1002/cam4.2691 Text en © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Cancer Research
Gruszczyńska, Magdalena
Bąk‐Sosnowska, Monika
Szemik, Szymon
Selected psychological aspects and medication adherence in oncological patients
title Selected psychological aspects and medication adherence in oncological patients
title_full Selected psychological aspects and medication adherence in oncological patients
title_fullStr Selected psychological aspects and medication adherence in oncological patients
title_full_unstemmed Selected psychological aspects and medication adherence in oncological patients
title_short Selected psychological aspects and medication adherence in oncological patients
title_sort selected psychological aspects and medication adherence in oncological patients
topic Clinical Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997052/
https://www.ncbi.nlm.nih.gov/pubmed/31837119
http://dx.doi.org/10.1002/cam4.2691
work_keys_str_mv AT gruszczynskamagdalena selectedpsychologicalaspectsandmedicationadherenceinoncologicalpatients
AT baksosnowskamonika selectedpsychologicalaspectsandmedicationadherenceinoncologicalpatients
AT szemikszymon selectedpsychologicalaspectsandmedicationadherenceinoncologicalpatients